Dyssomnias Clinical Trial
Official title:
Internet-delivered Cognitive Behaviour Therapy for Adolescents With Co-morbid Insomnia Attending Children and Youth Psychiatry: An Open Trial
Verified date | March 2018 |
Source | Uppsala University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Insomnia is a commonly reported comorbidity for adolescents with psychiatric conditions. It is well-known that insomnia can exacerbate the concurrent psychiatric symptom load. Treatment of insomnia has been extensively examined in adults, but studies with adolescents are sparse. The purpose of this pilot study is to assess the feasibility and efficacy of internet-based cognitive behavioral therapy for insomnia (iCBT) in outpatients of Children and Youth Psychiatry. Twenty-one adolescents will be recruited and receive 7 weeks of iCBT. Outcome will be measured at pre treatment, at post treatment and at a three months follow-up. Weekly assessments will also be made during treatment on primary outcome and a presumed process variable constructed for the purpose of this trial.
Status | Completed |
Enrollment | 21 |
Est. completion date | October 2017 |
Est. primary completion date | October 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 13 Years to 18 Years |
Eligibility |
Inclusion Criteria: - To fulfill the diagnostic criteria for insomnia - To have access to a computer with Internet connection - No previous or ongoing CBT for insomnia - No psychotropic medication or being on a stable dosage for at least six weeks before enrollment Exclusion Criteria: - Ongoing manic or psychotic episode - Being at high risk of triggering manic or psychotic episode - Ongoing sleep apnea |
Country | Name | City | State |
---|---|---|---|
Sweden | Uppsala University Hospital | Uppsala | Uppsala Län |
Lead Sponsor | Collaborator |
---|---|
Uppsala University Hospital | Karolinska Institutet, Uppsala University |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Insomnia Severity Index (ISI; Morin, 1993) | Given that this is an intervention study we are assessing changes in outcome over time. | Pre treatment, weekly during treatment (e.g. from date of treatment start for seven weeks until treatment is terminated), post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up | |
Secondary | The Core Consensus Sleep Diary (Core CSD; Carney et al., 2012) | Given that this is an intervention study we are assessing changes in outcome over time. | Pre treatment, weekly during treatment (e.g. from date of treatment start for seven weeks until treatment is terminated), post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up | |
Secondary | Symptoms Checklist (SCL-90; Derogatis et al., 1994) | Given that this is an intervention study we are assessing changes in outcome over time. | Pre treatment, post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up | |
Secondary | Montgomery-Åsberg Depression Rating Scale - Self report (MADRS-S; Svanborg & Åsberg, 1994) | Given that this is an intervention study we are assessing changes in outcome over time. | Pre treatment, post treatment (e.g. seven weeks after the patient has started treatment), 3 month follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02557880 -
Sleep Application Diary and Sleep Hygiene in Adolescents
|
N/A | |
Terminated |
NCT00750919 -
Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)
|
Phase 3 | |
Completed |
NCT00993850 -
Sleep Disturbance and Bipolar Disorder
|
Phase 3 | |
Completed |
NCT00561821 -
Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709)
|
Phase 3 | |
Completed |
NCT00631657 -
A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002)
|
Phase 3 | |
Active, not recruiting |
NCT00690196 -
Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms
|
N/A | |
Completed |
NCT00113906 -
Melatonin Treatment After Laparoscopic Cholecystectomy
|
Phase 2/Phase 3 | |
Recruiting |
NCT04995263 -
A Multicomponent Intervention for Prevention and Treatment of Sleep Disturbances in a Psychiatric Intensive Care Unit
|
N/A | |
Completed |
NCT00561574 -
A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001)
|
Phase 3 | |
Completed |
NCT01061242 -
Intensive Care Unit (ICU) Sleep Quality and Neurocognitive Performance
|
N/A | |
Recruiting |
NCT05565833 -
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
|
Phase 2 | |
Recruiting |
NCT04402619 -
Online Cognitive Behavior Therapy for Comorbid Sleep Problems in Alcohol Use Disorder
|
N/A | |
Completed |
NCT00000171 -
Study of Melatonin: Sleep Problems in Alzheimer's Disease
|
Phase 3 |